Managing Endometriosis with the Novel Treatment of Dienogest

About this activity

This presentation explores the use of Dienogest, a novel progestin, in the effective management of endometriosis. It highlights the drug’s mechanism of action, clinical benefits, safety profile, and role in reducing pain and lesion progression. The session will compare Dienogest with traditional therapies, emphasizing its suitability for long-term treatment. Participants will gain insights into patient selection, treatment protocols, and how Dienogest is improving quality of life for women living with endometriosis, especially in low-resource and primary care settings.